Newer developments in adult T-cell leukemia/lymphoma therapeutics. - Wikidata - wikimedia - TriplyDB

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

http://www.wikidata.org/entity/Q37864326

about

HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression.A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

P2860

Q33425096-D6C2D1DD-B72C-4443-B4B9-E0F27155C142 Q50145911-2B7D2589-85CE-46F9-B493-BD73F1574F63

P2860

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

http://www.wikidata.org/entity/Q37864326

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@en

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@nl

type

label

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@en

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@nl

prefLabel

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@en

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@nl

P1433

Q37864326-331A332F-367B-40BA-86B3-CE67E62FA41A

P1476

Q37864326-9BBB332B-19EB-4CF2-B7BA-B0751BD3553B

P2093

Q37864326-7D18875B-096C-4FFF-8629-1DB665D4BA5B

P2860

Q37864326-068613F5-12BD-4973-BA4B-F4F15D898C6D

Q37864326-0B1CA33B-C525-45A3-B07A-FA5347E04C6B

Q37864326-0C7F3956-00AB-47BF-94B9-E312EC518BE1

Q37864326-10C42D9F-B713-42EA-B832-D5E8D0A1681C

Q37864326-147F8CD3-C0A6-43D4-A96C-4DA7A8ABEEF0

Q37864326-17057BAF-0E3D-45DC-8BC0-49A542EC8E7F

Q37864326-201613C3-C719-4C39-84D0-57DF6F0F674A

Q37864326-24E45A85-AEE0-44EA-8619-8B4ECA8D80CD

Q37864326-29EE218B-483B-4A04-95C1-393492EA5D10

Q37864326-3791FE1B-EC6D-4CCD-810C-142DA8D53552

P304

Q37864326-CBC020E6-E423-41AB-832D-4F22010B390C

P31

Q37864326-6472E6EA-6381-4292-ADB6-955FF6636EBB

P356

Q37864326-0A250D0E-0946-4E48-B8F5-E407843990E8

P407

Q37864326-3CD74131-974E-46D0-8E9D-49A583A8793B

P433

Q37864326-2E756345-01DF-4DFA-953C-F655F1622C32

P478

Q37864326-6AE30B76-4C4E-4F9C-AC12-B2A99892A1F1

P577

Q37864326-CF3F4211-25ED-4B0D-81FA-920596FDBC47

P698

Q37864326-F5C4F4A5-39E2-4E51-B135-856D6ECE01E9

P921

Q37864326-EA8B1DBA-CEFB-4449-9535-6D036C1A2B26

P356

14656566.2011.571207

P1433

Expert Opinion on Pharmacotherapy

P1476

Newer developments in adult T-cell leukemia/lymphoma therapeutics.

@en

P2093

Constantin A Dasanu

http://www.w3.org/2001/XMLSchema#string

P2860

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome.

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy.

Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.

Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.

New therapeutic approaches for adult T-cell leukaemia.

HTLV-1 Tax and adult T-cell leukemia.

P304

1709-1717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.571207

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21486117

http://www.w3.org/2001/XMLSchema#string

P921